Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

(2021) Florian Krammer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents

(2021) Barbara H. Bardenheier et al.   VACCINE

Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021

(2021) Andrea Ossato et al.   European Journal of Hospital Pharmacy-Science and Practice

Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

(2021) Musha Chen et al.   Infectious Diseases of Poverty

Nursing Home Care in Crisis in the Wake of COVID-19

(2020) David C. Grabowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses

(2016) Miguel A. Hernán et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY